Clinical TrialID 6921
Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
NCT02651220
Acne
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6921
- Evidence Id
- 6921
- Core Evidence Id
- 6921
- Source Clinical Trial Id
- 6913
- Herb2 Clinical Trial Id
- HBCT006913
- Nct Id
- NCT02651220
- Title
- Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study Result
- Yes
- Study Condition
- Acne
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Epiduo® Forte Gel|DRUG: Adapalene and Benzoyl Peroxide Gel|DRUG: placebo gel
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult
- Enrollment
- 1001
- Outcome Measure
- Percent Change From Baseline to Week 12 in the Number of Inflamed Lesions., 12 weeks|Percent Change From Baseline to Week 12 in the Number of Non-inflamed Lesions., 12 weeks
- Sponsor Collaborator
- Actavis Inc.
- Funded By
- INDUSTRY
- Location
- Site 103, Mesa, Arizona, 85202, United States|Site 109, Tucson, Arizona, 85712, United States|Site 112, Anaheim, California, 92804, United States|Site 110, Long Beach, California, 90813, United States|Site 111, Los Angeles, California, 92210, United States|Site 104, San Diego, California, 92108, United States|Site 113, West Covina, California, 91790, United States|Site 101, Brandon, Florida, 33511, United States|Site 119, Jacksonville, Florida, 32256, United States|Site 114, Miami, Florida, 33015, United States|Site 115, Miami, Florida, 33175, United States|Site 116, Miramar, Florida, 33027, United States|Site 102, Arlington Heights, Illinois, 60005, United States|Site 105, Carmel, Indiana, 46032, United States|Site 120, New Albany, Indiana, 47150, United States|Site 107, Henderson, Nevada, 89052, United States|Site 106, High Point, North Carolina, 27262, United States|Site 108, Rhinelander, Wisconsin, 54501, United States|Site 117, Belize City, Belize|Site 118, Belize City, Belize
- Other Id
- 71491705
- Start Date
- 2015-11
- Primary Completion Date
- 2016-04
- Completion Date
- 2016-10
- First Posted
- 2016-01-08
- Results First Posted
- 2020-06-23
- Last Update Posted
- 2020-06-23
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02651220
- Title Cn
- Title En
- Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
- Bilingual Status
- semi_complete